{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:06:41Z","timestamp":1772575601725,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T00:00:00Z","timestamp":1383609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"crossref","award":["AP75732010"],"award-info":[{"award-number":["AP75732010"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.humpath.2013.10.018","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T10:33:36Z","timestamp":1383820416000},"page":"522-532","source":"Crossref","is-referenced-by-count":38,"title":["Optimal protocol for PTEN immunostaining; role of analytical and preanalytical variables in PTEN staining in normal and neoplastic endometrial, breast, and prostatic tissues"],"prefix":"10.1016","volume":"45","author":[{"given":"Oscar","family":"Maiques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Santacana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Valls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mirantes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f3nia","family":"Gatius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Andr\u00e9s","family":"Garc\u00eda Dios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Amant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Christian","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Dolcet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.10.018_bb0005","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2013.10.018_bb0010","first-page":"235","article-title":"PTEN regulatory functions in tumor suppression and cell biology","volume":"10","author":"Chu","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.humpath.2013.10.018_bb0015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81663-3","article-title":"Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association","volume":"3","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2013.10.018_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.humpath.2013.10.018_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/erc.0.0100203","article-title":"Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer","volume":"10","author":"Terakawa","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2013.10.018_bb0030","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.humpath.2006.05.007","article-title":"PIK3CA gene mutation in endometrial carcinoma: correlation with PTEN and K-RAS alterations","volume":"37","author":"Velasco","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.10.018_bb0035","article-title":"Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer","author":"Pradeep","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2013.10.018_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/emmm.200900041","article-title":"Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors","volume":"1","author":"Mendes-Pereira","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.humpath.2013.10.018_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","article-title":"PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients","volume":"6","author":"Nagata","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2013.10.018_bb0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2007.08.030","article-title":"A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistant in breast cancer","volume":"12","author":"Berns","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2013.10.018_bb0055","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccr.2010.10.025","article-title":"Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation","volume":"18","author":"Liang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2013.10.018_bb0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/modpathol.3800347","article-title":"Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities","volume":"18","author":"Pallares","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.10.018_bb0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.10.018_bb0070","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.prp.2007.01.003","article-title":"Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index","volume":"203","author":"Kapucuoglu","year":"2007","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2013.10.018_bb0075","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1158\/1078-0432.CCR-11-1244","article-title":"PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients","volume":"17","author":"Lotan","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.10.018_bb0080","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0002-9440(10)65227-3","article-title":"Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast","volume":"155","author":"Perren","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2013.10.018_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0022-4731(90)90306-D","article-title":"Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line","volume":"35","author":"Croxtall","year":"1990","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.humpath.2013.10.018_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02618053","article-title":"Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture","volume":"19","author":"Way","year":"1983","journal-title":"In Vitro"},{"key":"10.1016\/j.humpath.2013.10.018_bb0095","doi-asserted-by":"crossref","first-page":"10320","DOI":"10.1073\/pnas.171060098","article-title":"Mutation of PTEN\/MMAC1 in mice causes neoplasias in multiple organ systems","volume":"98","author":"Podsypanina","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2013.10.018_bb0100","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1242\/dmm.011445","article-title":"An inducible Knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias","volume":"6","author":"Mirantes","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.humpath.2013.10.018_bb0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5858\/2010-0702-RAIR.1","article-title":"Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue","volume":"135","author":"Engel","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2013.10.018_bb0110","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/hmg\/ddi492","article-title":"Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer","volume":"15","author":"Agrawal","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2013.10.018_bb0115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1593\/neo.04595","article-title":"mTOR promotes survival and astrocytic characteristics induced by Pten\/AKT signaling in glioblastoma","volume":"7","author":"Hu","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.humpath.2013.10.018_bb0120","first-page":"1820","article-title":"Differential expression of MMAC\/PTEN in glioblastoma multiforme: relationship to localization and prognosis","volume":"59","author":"Sano","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.10.018_bb0125","first-page":"4291","article-title":"Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage","volume":"59","author":"McMenamin","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.10.018_bb0130","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/labinvest.3700286","article-title":"FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis","volume":"85","author":"Dolcet","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2013.10.018_bb0135","first-page":"3935","article-title":"Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies","volume":"57","author":"Tashiro","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.10.018_bb0140","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/jcp.2008.056101","article-title":"Molecular pathology of endometrial carcinoma; practical aspects from the diagnostic and therapeutical view points","volume":"62","author":"Llobet","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2013.10.018_bb0145","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"George","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2013.10.018_bb0150","first-page":"3254","article-title":"PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma","volume":"58","author":"Levine","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.10.018_bb0155","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/ijc.10542","article-title":"PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy","volume":"100","author":"Kanamori","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2013.10.018_bb0160","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0002-9440(10)65040-7","article-title":"Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors","volume":"156","author":"Gimm","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2013.10.018_bb0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ng.556","article-title":"Subtle variations in PTEN dose determine cancer susceptibility","volume":"42","author":"Alimonti","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2013.10.018_bb0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nature10275","article-title":"A continuum model for tumour suppression","volume":"476","author":"Berger","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2013.10.018_bb0175","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.bjc.6602926","article-title":"PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer","volume":"94","author":"Fujita","year":"2006","journal-title":"Br J Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713004498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713004498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T19:50:21Z","timestamp":1647028221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713004498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0046817713004498"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.10.018","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}